Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
K-252a
i
Other names:
K-252a, K252a , SF 2370
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Kyowa Kirin, Teva
Drug class:
Trk inhibitor, PKC inhibitor, TrkA receptor antagonist, Hepatocyte growth factor inhibitor
Related drugs:
‹
repotrectinib (27)
SIM1803-1A (5)
FCN-098 (3)
OPN-7486 (1)
BAY 2731954 (1)
AGX87 (0)
ONO-7579 (0)
TL118 (0)
TY-2136b (0)
XZP-5955 (0)
TSR-011 (0)
AEB071 (17)
IDE196 (9)
AHT956 (2)
RO-31-8220 (2)
AB-106 (5)
VMD-928 (0)
TZLS-201 (0)
AV-299 (2)
CLM-101 (0)
MP0250 (0)
ABT-510 (0)
repotrectinib (27)
SIM1803-1A (5)
FCN-098 (3)
OPN-7486 (1)
BAY 2731954 (1)
AGX87 (0)
ONO-7579 (0)
TL118 (0)
TY-2136b (0)
XZP-5955 (0)
TSR-011 (0)
AEB071 (17)
IDE196 (9)
AHT956 (2)
RO-31-8220 (2)
AB-106 (5)
VMD-928 (0)
TZLS-201 (0)
AV-299 (2)
CLM-101 (0)
MP0250 (0)
ABT-510 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 G697R
Acute Myelogenous Leukemia
FLT3 G697R
Acute Myelogenous Leukemia
K-252a
Sensitive: D – Preclinical
K-252a
Sensitive
:
D
K-252a
Sensitive: D – Preclinical
K-252a
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login